IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
This concern warrants appropriate screening and consideration of personal cancer risk factors before use
AOD-9604 targets beta-3 adrenergic receptors in adipose tissue to stimulate lipolysis directly, without affecting appetite, blood glucose, or the central nervous system
Gut permeability, inflammation, and metabolic disease
Regulators reflect this: most of these compounds are classified "for research use only" in the US and EU, and the FDA has issued warning letters to companies marketing unapproved peptide products
Day one is when you add water